Tech Company Financing Transactions
Sequence Bio Funding Round
On 8/4/2016, Sequence Bio secured $3.9 million in Seed financing from Data Collective and private investors.
Transaction Overview
Company Name
Announced On
8/4/2016
Transaction Type
Venture Equity
Amount
$3,900,000
Round
Seed
Investors
Data Collective (Lead Investor) (Zachary Bogue)
Proceeds Purpose
This investment will accelerate our already rapid growth. With this unique network of talent, advisors and expertise in big data supporting us, we have never been better positioned for success in drug discovery and precision medicine.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
139 Water St. 2nd Floor 2
St. John's NL, A1C 1B2
Canada
St. John's NL, A1C 1B2
Canada
Phone
Website
Email Address
Overview
Sequence Bio is a Newfoundland and Labrador company leading a 100,000 person genome sequencing project. By unlocking transformative insights into human biology, we can improve how we treat diseases and develop medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tyler Wish
Browse more venture capital transactions:
Prev: 8/4/2016: Central Logic venture capital transaction
Next: 8/4/2016: Panoply venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs